All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional.
The PsOPsA Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
Introducing
Now you can personalise
your PsOPsA Hub experience!
Bookmark content to read later
Select your specific areas of interest
View content recommended for you
Find out moreThe PsOPsA Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the PsOPsA Hub cannot guarantee the accuracy of translated content. The PsOPsA Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The PsOPsA Hub is supported by educational grants. All educational content is developed independently by SES in collaboration with our expert steering committee, with no input or influence from financial supporters. We would like to express our gratitude to the following companies for their support: • UCB: For website development, launch, and ongoing maintenance. • UCB and Bristol Myers Squibb: For educational content and news updates.
Are the EULAR PsA guidelines fit for modern day treatment of PsA?
During The European Congress of Rheumatology (EULAR) 2023, the Psoriasis and Psoriatic Arthritis Hub was pleased to speak with Alice Gottlieb, Icahn School of Medicine, New York, US. and Joseph Merola, Harvard Medical School, Boston, US. We asked, Are the EULAR psoriatic arthritis (PsA) guidelines fit for modern day treatment of PsA?
Are the EULAR PsA guidelines fit for modern day treatment of PsA?
The pair discuss reasons why PsA is important to diagnose and treat as well summarizing the recent updated EULAR recommendations for the management of PsA. Merola goes on to discuss the roles of dermatologists, rheumatologists and the wider multidisciplinary team and reviews how their collaborative care is vital for appropriate diagnosis, treatment, and comorbidity screening. Merola also places emphasis on the importance of facilitated communication between physicians to allow for the most effective care for patients.
Your opinion matters
10 votes - 50 days left ...
Related articles
Newsletter
Subscribe to get the best content related to Psoriasis and Psoriatic Arthritis delivered to your inbox